Prestige Consumer Healthcare
PBH
47.57
+1.13
+2.43%
Prestige Consumer Healthcare
US · PBH
#2733 by market cap
Listed 1970
47.57
+1.13
+2.43%
Live - 5344 symbols - heartbeat 451s ago
· 2026-10-07 19:54
After-hours
47.57
0.00%
- Market cap
- 2.25B
- P/E (TTM)i
- 13.32
- P/Bi
- 1.18
- EPSi
- 3.91
- Div yieldi
- 0.00%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on PBH?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 2 analysts
Buy
Avg price target
72.00 +51.4%
Price target rangecurrent 47.57
Low72.00
Avg72.00
High72.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (21)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-08-06 | CCORF | -- | BUY | 72.00 |
| 2026-08-06 | William Blair | -- | BUY | -- |
| 2026-06-01 | CCORF | -- | BUY | 72.00 |
| 2026-05-15 | CCORF | -- | BUY | 72.00 |
| 2026-05-14 | Oppenheimer | -- | HOLD | -- |
| 2026-05-13 | William Blair | -- | BUY | -- |
| 2026-05-07 | Oppenheimer | -- | BUY | 65.00 |
| 2026-03-23 | CCORF | -- | BUY | 86.00 |
| 2026-03-23 | William Blair | -- | BUY | -- |
| 2026-03-19 | RBC Capital | -- | BUY | 91.51 |
| 2026-03-17 | William Blair | -- | BUY | -- |
| 2026-02-23 | Oppenheimer | -- | BUY | -- |
| 2026-02-11 | Oppenheimer | -- | BUY | 77.00 |
| 2026-02-06 | CCORF | -- | BUY | 86.00 |
| 2026-02-05 | William Blair | -- | BUY | -- |
| 2026-01-14 | CCORF | -- | BUY | 88.00 |
| 2026-01-13 | William Blair | -- | BUY | -- |
| 2026-01-13 | Oppenheimer | -- | BUY | -- |
| 2025-11-07 | CCORF | -- | BUY | 88.00 |
| 2025-11-06 | William Blair | -- | BUY | -- |
| 2025-10-21 | Oppenheimer | -- | BUY | 72.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Oppenheimer moved from Buy to Hold on 2026-05-14.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-05-14 | Oppenheimer | BUY → HOLD | -- |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2027/Q1 | 2026-08-06 | -- | ±9.31% | +2.74% (in line) |
| 2026/Q4 | 2026-05-13 | After close | ±9.47% | -11.35% (beat) |
| 2026/Q3 | 2026-02-05 | -- | ±5.33% | -2.21% (in line) |
| 2026/Q2 | 2025-11-06 | -- | ±8.48% | +2.56% (in line) |
| 2026/Q1 | 2025-08-07 | -- | -- | -10.05% |
| 2025/Q4 | 2025-05-08 | -- | -- | +6.92% |
| 2025/Q3 | 2025-02-06 | -- | -- | +14.78% |
| 2025/Q2 | 2024-11-07 | -- | -- | +3.16% |
| 2025/Q1 | 2024-08-08 | -- | -- | -1.55% |
| 2024/Q4 | 2024-05-14 | After close | ±3.78% | -7.01% (beat) |
| 2024/Q3 | 2024-02-08 | -- | ±4.95% | +9.36% (beat) |
| 2024/Q2 | 2023-11-02 | -- | ±16.20% | -0.57% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.